Play

If you’ve had three doses of an mRNA vaccine against Covid you are much less likely to require hospitalization, require ICU level care, or die from Covid-19, even with the now dominant Omicron variant, than if you aren’t vaccinated at …

There is some protection against Omicron with current vaccines, Elizabeth Tracey reports Read more »

Play

Children younger than five comprise the last group in whom a vaccine against Covid is currently being tested. Jonathan Zenilman, an infectious disease expert at Johns Hopkins, says late spring may be when enough data will be in for an …

Vaccines against Covid for the very young are just around the corner, Elizabeth Tracey reports Read more »

Play

Vaccination against the human papilloma virus, or HPV, all but eliminates cervical cancer in those who receive the vaccine early and complete the vaccine series, a study from the UK finds. William Nelson, director of the Kimmel Cancer Center at …

The benefits of the HPV vaccine are proven in a new study, Elizabeth Tracey reports Read more »

Play

The Covid-19 spike protein allows it to attach to cells and infect them, and it’s been a primary target for vaccines and antibodies. Now a new monoclonal antibody directed against a region of this protein that really doesn’t change very …

A new monoclonal antibody may work against many variants of Covid-19, Elizabeth Tracey reports Read more »

Play

Another monoclonal antibody against Covid-19 has been developed and appears to work in reducing severe disease and hospitalization. This one is unique, however, according to Brian Garibaldi, a critical care medicine expert at Johns Hopkins. Garibaldi: The interesting thing about …

Do we really need a new monoclonal antibody for Covid-19? Elizabeth Tracey reports Read more »

Play

Monoclonal antibodies remain a treatment option for those in early stages of Covid infection, even in the face of new oral medications that likely will be available soon. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says the …

If you’ve been exposed to Covid-19, should you have monoclonal antibody treatment? Elizabeth Tracey reports Read more »

Play

Both Pfizer and Merck have recently revealed promising data on oral medicines for early Covid-19 infection, with both companies on the threshold of widespread use of the drugs. Brian Garibaldi, a critical care medicine expert at Johns Hopkins, says he …

Two new oral medicines for Covid-19 are poised for widespread use, Elizabeth Tracey reports Read more »